Centrifugal Blood Pumps Market To Reach $136.1 Million By 2030

 

The global Centrifugal Blood Pumps Market size is expected to reach USD 136.1 million by 2030, registering a CAGR of 5.0% during the forecast period, according to a new report by Grand View Research, Inc.  Demand for centrifugal blood pumps is increasing owing to its several advantages such as low maintenance costs, small in size, and less capital investment. Thus, such advantages offered by centrifugal blood pumps are estimated to fuel the market growth during the forecast period.

Growing clinical experience and cardiotomy suction devices have led to a significant increase in usage of mechanical centrifugal blood pumps and to the improvement of outcomes after short and long-term support. As the interventional methods in the cardiovascular field continue to develop and a majority of critically ill patients undergo treatment, the demand for mechanical centrifugal blood pumps is increasing drastically in this field.

Changing lifestyles and an increase in the prevalence of lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as diabetes, obesity, and cardiovascular diseases coupled with the rising number of geriatric population are fueling the demand for cardiovascular procedures. Treatment of such diseases involves the use of cardiotomy suction devices, which, in turn, is expected to drive the market over the forecast period.

List of Key Players in the Centrifugal Blood Pumps Market

• Medtronic
• LivaNovaplc
• Qura srl
• Abbott Laboratories
• Terumo Corporation
• Braille Biomedica Ltd.
• Getinge AB
• 3M
• Baxter International

Related Press Release@ Centrifugal Blood Pumps Market Report

Centrifugal Blood Pumps Market Report Highlights

• The electronic segment held the largest revenue share in 2023. High product efficacy is a major factor augmenting segment growth.
• The hospitals segment is leading market growth due to the increasing number of patient visits and advanced infrastructure in hospitals as compared to other healthcare facilities.
• North America held the largest revenue share in the market in 2023 and is predicted to maintain its dominance over the forecast period. This is attributable to strong per capita healthcare spending and favorable healthcare policies that have led to the introduction of cardiotomy suction devices.

Centrifugal Blood Pumps Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 101.6 million
Revenue forecast in 2030	USD 136.1 million
Growth Rate	CAGR of 5.0% from 2024 to 2030
Actual data	2018 - 2023
Forecast period	2024 - 2030

 

Centrifugal Blood Pumps Market Segmentation

Grand View Research has segmented the global centrifugal blood pumps market report based on type, end use, and region: 

Centrifugal Blood Pumps Type Outlook (Revenue, USD Million, 2018 - 2030)

• Electronic
• Mechanical

Centrifugal Blood Pumps End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Centrifugal Blood Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com